IL-27 Antibody (355028) [Alexa Fluor® 647]

• Reactivity: Mu
• Applications: IP
• Clone: 355028
• Clonality: Monoclonal
• Host: Rat
• Conjugate: Alexa Fluor 647

IL-27 Antibody (355028) [Alexa Fluor® 647] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant mouse IL-27 heterodimer
  Tyr19-Pro228 (EBI3) and Phe29-Ser234 (p28)
  Accession # O35228 (EBI3) & Q8K3I6 (p28)
• Specificity: Detects mouse IL-27 heterodimer in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant mouse (rm) IL-27 p28, rmIL‑27 EBI‑3, or recombinant human (rh) IL-27 heterodimer is observed. In Western blots, no cross-reactivity with rmI
• Isotype: IgG2a
• Clonality: Monoclonal
• Host: Rat
• Purity Statement: Protein A or G purified

Applications/Dilutions

• Dilutions:
  • Immunoprecipitation

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for IL-27 Antibody (355028) [Alexa Fluor® 647]

• IL-27 p28 subunit
• IL-27 subunit alpha
• IL27
• IL-27
• IL27A
• IL-27-A
• IL27-A
• IL27p28
• IL30
• interleukin 27
• interleukin 30
• interleukin-27 subunit alpha
• MGC71873
• p28IL-27A

Background

Interleukin 27 (IL-27) is a secreted heterodimeric cytokine comprised of the IL-12 p35-related protein, p28, and the IL-12 p40-related protein, EBI3 (Epstein-Barr virus‑induced gene 3). IL-27 is expressed by monocytes, endothelial cells and dendritic cells. It binds TCCR/WSX-1 on naïve CD4⁺ T cells and induces the expression of a functional IL-12 receptor, allowing IL-12-induced Th1 polarization. Human EBI3 is 61% amino acid (aa) identical to mouse EBI3 and includes an 20 aa signal peptide and a 209 aa mature protein with two fibronectin type III domains.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.